Sector: Health Care | Focus: Life Sciences Tools & Services
HQ: Durham, North Carolina
Financial Risks
IQVIA faces risks from business disruptions (natural disasters, pandemics, conflicts), potential contract terminations or delays, market growth uncertainties, new service development challenges, data restrictions, regulatory compliance failures, security breaches, and integration difficulties. Economic conditions, tax changes, and sales to government entities also pose risks. The company's debt covenants and legal proceedings add further uncertainty.
Financial Upside
IQVIA's revenue growth is expected to continue, with increases in Technology & Analytics Solutions and Research & Development Solutions. A significant backlog of $31.1 billion is expected to convert to revenue, particularly in Research & Development. The company's liquidity position, with $1,572 million in cash, and access to credit facilities, suggests sufficient funding for operations and acquisitions. Repurchases of common stock are also a potential upside.